Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
Clinical trial NCT00478062 · TERMINATED
Trial details
- NCT number
- NCT00478062
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.